|
Advertise About
Live
TSX24,847▲ +0.44%
S&P 5005,612▲ +0.31%
Gold$3,342▼ −0.19%
BTC$108,240▲ 1.82%
WTI$78.40▲ +1.12%
USD/CAD1.3612▼ −0.08%
Silver$33.80▲ +0.62%
Uranium$92.50▲ +2.44%
TSX24,847▲ +0.44%
S&P 5005,612▲ +0.31%
Gold$3,342▼ −0.19%
BTC$108,240▲ 1.82%
WTI$78.40▲ +1.12%
USD/CAD1.3612▼ −0.08%
Silver$33.80▲ +0.62%
Uranium$92.50▲ +2.44%
🧬
Biotech & Life Sciences
Genomics
Clinical trials, drug approvals, genomics, and the Canadian life-sciences companies to watch.
Biotech Now
AMGN
GILD
VRTX
REGN
BIIB
MRNA
Genomics
July 4, 2026
Canada’s $200M Genomics Strategy: How Federal Investment Is Reshaping Precision Medicine
Ottawa's landmark genomics commitment is funding 14 research programs, creating a national biobank of 500,000 Canadians, and positioning Canada as a global precision medicine hub.
Read full story →
Free Daily Briefing

The Boreal Brief

Markets, Bitcoin, Gold. 5 minutes before the open. Join 12,000+ Canadian investors.

No spam. Unsubscribe anytime.